Published in Br Heart J on December 01, 1992
A saphenous vein graft aneurysm with fistula development to the right atrium: surgical management of a rare bypass graft complication. Can J Cardiol (2008) 0.95
A case of giant saphenous vein graft aneurysm followed serially after coronary artery bypass surgery. Open Med (Wars) (2016) 0.75
Aneurysm of an autologous aorta to right coronary artery reverse saphenous vein graft presenting as a mediastinal mass: a case report. Cases J (2008) 0.75
Aortic dissection: anatomy, consequences, and causes. Am Heart J (1981) 2.37
Dehiscence of infected aortocoronary vein graft suture lines. Cause of late pseudoaneurysm of ascending aorta. Br Heart J (1983) 1.09
False aneurysm of ascending aorta after aortocoronary bypass grafting. Am J Cardiol (1983) 0.98
Work in progress. Transcatheter thermal venous occlusion: a new technique. Radiology (1982) 0.95
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J (1989) 4.62
Pre-hospital opiate and aspirin administration in patients with suspected myocardial infarction. BMJ (1994) 2.46
Treatment of atrial fibrillation in a district general hospital. Br Heart J (1994) 2.40
ABC of palliative care. Non-malignant conditions. BMJ (1998) 2.24
Secondary harmonic imaging overestimates left ventricular mass compared to fundamental echocardiography. Eur J Echocardiogr (2003) 2.11
Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction. Heart (1997) 2.01
Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. Br Heart J (1988) 1.75
Direct admission to the coronary care unit by the ambulance service for patients with suspected myocardial infarction. Heart (1997) 1.60
Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J (1996) 1.59
Early treatment of myocardial infarction in the community. Br Med J (1978) 1.58
Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. Br Heart J (1993) 1.40
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J (1995) 1.38
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG. Br Heart J (1992) 1.22
Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Lancet (1990) 1.20
Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Blood Coagul Fibrinolysis (1995) 1.16
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Diagnosis and treatment of digoxin toxicity. Postgrad Med J (1993) 1.06
Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol (1977) 1.06
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med (1983) 1.00
Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab (1984) 0.99
Malignant hypertension associated with use of oral contraceptives. Br Heart J (1975) 0.98
Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol (1983) 0.97
Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol (1984) 0.97
Serial measurements of left ventricular dimensions by echocardiography. Assessment of week-to-week, inter- and intraobserver variability in normal subjects and patients with valvular heart disease. Br Heart J (1980) 0.96
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent. Arch Intern Med (1978) 0.95
Relation between prognosis and the blood pressure before and during treatment of hypertensive patients. Clin Sci Mol Med Suppl (1978) 0.95
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart (2006) 0.94
Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation (1981) 0.93
Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension. Am J Cardiol (1983) 0.93
Optimising direct access ECHO referral in suspected heart failure. Scott Med J (2000) 0.93
Bleeding pseudocysts and pseudoaneurysms in chronic pancreatitis. Br J Surg (1992) 0.92
Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension. J Am Coll Cardiol (1989) 0.91
Iliac arteriovenous fistula following lumbar disc surgery treated by percutaneous endoluminal stent grafting. Br J Surg (1996) 0.91
Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med (1983) 0.90
Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm. Int J Cardiol (1995) 0.89
Management of suspected myocardial infarction before admission: updated audit. BMJ (1998) 0.88
Angiographic embolization of the distal internal mammary artery as an adjunct to regional chemotherapy in inoperable breast carcinoma. J Vasc Interv Radiol (1995) 0.88
Left ventricular hypertrophy in hypertension. N Engl J Med (1999) 0.88
Thrombogenesis in mitral regurgitation and aortic stenosis. Angiology (1996) 0.87
Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. Am J Cardiol (1981) 0.87
Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy. Am J Cardiol (1992) 0.86
Antihypertensive and renal effects of tienilic acid. Postgrad Med J (1979) 0.86
Beta-adrenoreceptor blockade in hypertension. Am J Med (1976) 0.86
Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction. Am J Cardiol (1997) 0.85
Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy. Br Heart J (1992) 0.84
Natural biventricular hypertrophy in normotensive rats. I. Physical and hemodynamic characteristics. Am J Physiol (1979) 0.84
CABG in the elderly: the Glasgow experience. Gerontology (1989) 0.84
Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase. Br Heart J (1994) 0.83
Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension. Circulation (1982) 0.83
Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. Am J Cardiol (1995) 0.83
Time course of plasma markers of collagen turnover in patients with acute myocardial infarction. Heart (2004) 0.83
Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differences. Arch Intern Med (1977) 0.83
Acute myocardial infarction: a rare complication of the thrombotic tendency in nephrotic syndrome. Br J Clin Pract (1994) 0.82
Diurnal variation of blood pressure in elderly patients with essential hypertension. J Am Geriatr Soc (1984) 0.82
A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction. Br J Clin Pharmacol (1991) 0.82
Management of renal stab wounds by arteriographic embolisation. Scand J Urol Nephrol (1994) 0.82
Hemodynamic, reflexive, and metabolic alterations induced by acute and chronic timolol therapy in hypertensive man. Circulation (1978) 0.82
Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Drugs (1987) 0.81
Pheochromocytoma crisis induced by saralasin. Relation of angiotensin analogue to catecholamine release. N Engl J Med (1976) 0.81
An audit of emergency echocardiography in a district general hospital. Int J Cardiol (1993) 0.81
Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol. Circulation (1987) 0.81
Comparison of 12-lead and computer-analysed 3 orthogonal lead electocardiogram in coronary artery disease. Br Heart J (1976) 0.80
Comparison of intravenous bumetanide and frusemide during open heart surgery. Postgrad Med J (1975) 0.80
Anatomical basis of intra-arterial chemotherapy for patients with locally advanced breast cancer. Br J Surg (1996) 0.79
Standardized stress and hypertension: comparison of effect of propranolol and methyldopa. Br J Clin Pharmacol (1978) 0.79
Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. Int J Cardiol (1995) 0.79
Hemodynamic correlates of prolonged thiazide therapy: comparison of responders and nonresponders. Clin Pharmacol Ther (1977) 0.79
Selective angiographically delivered regional chemotherapy in patients with locally advanced or recurrent breast cancer: a feasibility study. J Vasc Interv Radiol (1998) 0.78
Pharmacologic and physiologic considerations of adrenoceptor blockade. Am J Med (1983) 0.78
Impaired systemic arterial compliance in borderline hypertension. Am Heart J (1984) 0.78
Electrocardiographic evidence of myocardial salvage after thrombolysis in acute myocardial infarction. Br Heart J (1989) 0.78
The role of nuclear cardiology in hypertension. Nucl Med Commun (1994) 0.77
Systemic and renal effects of enalapril and its effects on cardiac mass. J Hypertens Suppl (1984) 0.77
Hemodynamic effects of intravenous labetalol in essential hypertension. Clin Pharmacol Ther (1983) 0.77
A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction. Br Heart J (1991) 0.77
Clinical and hemodynamic determinants of left ventricular dimensions. Arch Intern Med (1984) 0.77
Effect of blood pressure control on left ventricular hypertrophy in patients with essential hypertension. Clin Sci (Lond) (1980) 0.77
Hypertension and coronary artery disease. Med Clin North Am (1997) 0.77
The interface of hypertension and ischemic heart disease. Curr Opin Cardiol (1995) 0.77
ECG alterations with progressive left ventricular hypertrophy in spontaneous hypertension. Clin Exp Hypertens (1978) 0.77
The problem of obesity and hypertension. Hypertension (1983) 0.77
The value of light reflection rheography as a screening tool for deep venous thrombosis. Br J Radiol (1997) 0.76
Obesity and essential hypertension. Contrib Nephrol (1982) 0.76
Indications for beta-adrenoceptor blocking drugs in hypertension. Postgrad Med J (1976) 0.76
Limited clinical utility of CT coronary angiography in a district hospital setting. QJM (2010) 0.76
Regression of electrocardiographic left ventricular hypertrophy following treatment of primary hyperaldosteronism. J Hum Hypertens (1988) 0.76
Systolic and diastolic function following regression of left ventricular hypertrophy in hypertension. J Hypertens Suppl (1991) 0.76
Pericardiocentesis practice in the United Kingdom. Int J Clin Pract (2007) 0.76
Haemorrhage following penetrating gluteal trauma. Br J Surg (1994) 0.76
Hypertension and myocardial infarction. J Am Coll Cardiol (1983) 0.76
Impact of regression of left ventricular hypertrophy on cardiac function in hypertension. Eur Heart J (1992) 0.75
Prevalence of angiographic atherosclerotic renal artery disease and its relationship to the anatomical extent of peripheral vascular atherosclerosis. Nephrol Dial Transplant (1999) 0.75
New Zealand death certificates. N Z Med J (1999) 0.75
New Zealand Preferred Medicines Centre. N Z Med J (1993) 0.75
Pneumonitis complicating selective intra-arterial chemotherapy for locally advanced breast carcinoma. Postgrad Med J (1996) 0.75
Detection of pneumothorax by accident and emergency officers and radiologists on single chest films. Arch Emerg Med (1993) 0.75